BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//YourOrganization//EventDownload//DE
CALSCALE:GREGORIAN
METHOD:PUBLISH
BEGIN:VEVENT
UID:6a4e36913e72d@www.leap-up.com
DTSTAMP:20260708T133753Z
DTSTART:20260826T150000
DTEND:20260826T170000
SUMMARY:AI-Driven CDMO Solutions for Advanced Protein Expression and Antibody Drug Development
DESCRIPTION:The demand for high-quality recombinant proteins and antibody-drug conjugates (ADCs) continues to grow\, yet the development pipeline remains challenged by long timelines\, high failure rates\, and escalating costs. Creative BioMart's AI-driven CDMO platform addresses these bottlenecks head-on by seamlessly integrating artificial intelligence with experimental biology.\nIn this webinar\, Dr. Zhu will introduce Creative BioMart's integrated AI platform\, which enables accurate 3D structure prediction\, affinity maturation\, immunogenicity risk assessment\, and de novo antibody design — significantly reducing development time and cost. The session will cover our GMP-compliant facilities\, scalable mammalian and microbial expression systems\, and comprehensive quality control processes. Attendees will learn how our AI-first\, dry-wet closed-loop approach achieves high success rates in antibody engineering and membrane protein production\, supporting next-generation biotherapeutics.
END:VEVENT
END:VCALENDAR